
|Videos|August 10, 2021
Pharmacist Medication Insights: Octagam for Chronic Immune Thrombocytopenic Purpura
Author(s)Saro Arakelians, PharmD
Octagam 10% is indicated for the treatment of chronic immune thrombocytopenic purpura in adults and dermatomyositis (DM) in adults
Advertisement
Octagam 10% is an immune globulin intravenous (human) liquid preparation indicated for the treatment of:
- Chronic immune thrombocytopenic purpura (ITP) in adults
- Dermatomyositis (DM) in adults
Further, Octagam 10% is the first and only intravenous immunoglobulin to be indicated for the treatment of adult dermatomyositis.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
McKesson ideaShare 2026: Building Specialty and Infusion Capacity From the Ground Up
2
McKesson ideaShare 2026: Recapping Key Insights from Denver
3
McKesson ideaShare 2026: What Does It Take to Sustain a Rural Independent Pharmacy? Sandie Kueker, RPh, Explains
4
Ammoxetine: Emerging Data from a Phase 2 Antidepressant Trial
5




















































































































